Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).

Pfizer

Status and phase: Completed; Phase 4

Conditions: Colorectal Neoplasms

Treatments: Procedure: Blood draw

Study type: Interventional

Funder types: Industry

Identifiers

NCT00140036

A5961020

CPTAIV-0020-366

Details and patient eligibility

About

This protocol describes procedures for the collection of blood samples for the intent of determining genetic contribution to the safety and efficacy of CPT/FU/LV.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participation in studies employing treatment with irinotecan and a signed informed consent.

Exclusion criteria

• None.

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)